Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Microcomputed Tomography Is a Precise Method That Allows for Topographical Characterization of Lymph Nodes and Lymphatic Vessels.

Fournier DE, Groh AMR, Nair SM, Norley CJD, Pollmann SI, Holdsworth DW, Power NE, Beveridge TS.

Lymphat Res Biol. 2019 Sep 4. doi: 10.1089/lrb.2019.0007. [Epub ahead of print]

PMID:
31483190
2.

Effects of Introducing a Secure Web-based Messenger Application for Communication Among Non-consultant Hospital Doctors (NCHDs).

Corbett M, Chapman L, O'Shea J, Canning P, Sebaoui S, O'Sullivan D, Power N, O'Connor M.

Cureus. 2019 Jul 31;11(7):e5285. doi: 10.7759/cureus.5285.

3.

Early experience with chemotherapy intensification for poor prognosis metastatic germ cell cancer and unfavorable tumor marker decline.

Batra A, Ernst S, Potvin K, Fernandes R, Power N, Vanhie J, Winquist E.

Can Urol Assoc J. 2019 Jul 23. doi: 10.5489/cuaj.5802. [Epub ahead of print]

PMID:
31348750
4.

Decision Aids for Prostate Cancer Screening Choice: A Systematic Review and Meta-analysis.

Riikonen JM, Guyatt GH, Kilpeläinen TP, Craigie S, Agarwal A, Agoritsas T, Couban R, Dahm P, Järvinen P, Montori V, Power N, Richard PO, Rutanen J, Santti H, Tailly T, Violette PD, Zhou Q, Tikkinen KAO.

JAMA Intern Med. 2019 Jun 24. doi: 10.1001/jamainternmed.2019.0763. [Epub ahead of print]

5.

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.

Mason RJ, Wood L, Kapoor A, Basappa N, Bjarnason G, Boorjian SA, Breau RH, Cagiannos I, Jewett MAS, Karakiewicz PI, Kassouf W, Kollmannsberger C, Lalani AA, Lattouf JB, Lavallée LT, Pautler S, Power N, Richard P, So A, Tanguay S, Rendon RA.

Can Urol Assoc J. 2019 Jun;13(6):166-174. doi: 10.5489/cuaj.5786. No abstract available.

6.

Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy.

McAlpine K, Lavallée LT, Stacey D, Moodley P, Cagiannos I, Morash C, Black PC, Kulkarni GS, Shayegan B, Kassouf W, Siemens R, So A, Leveridge MJ, Boorjian SA, Daneshmand S, Smith AB, Power N, Izawa J, Drachenberg DE, Fairey A, Rendon RA, Breau RH.

J Urol. 2019 May 17:101097JU0000000000000341. doi: 10.1097/JU.0000000000000341. [Epub ahead of print]

PMID:
31099720
7.

Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes.

Wong NC, Alvim RG, Sjoberg DD, Shingarev R, Power NE, Spaliviero M, Murray KS, Benfante NE, Hakimi AA, Russo P, Coleman JA.

Eur Urol Focus. 2019 Apr 24. pii: S2405-4569(19)30110-5. doi: 10.1016/j.euf.2019.04.003. [Epub ahead of print]

PMID:
31029560
8.

Accessory right spermatic ganglion: possible embryological basis and clinical significance.

Nair SM, Power NE, Beveridge TS.

Surg Radiol Anat. 2019 Aug;41(8):973-976. doi: 10.1007/s00276-019-02180-4. Epub 2019 Feb 28.

PMID:
30820646
9.

The oncological outcomes of small cell carcinoma of the bladder.

Williams HA, Punjani N, Khan O, Power NE.

Can Urol Assoc J. 2018 Dec 3:260-265. doi: 10.5489/cuaj.5579. [Epub ahead of print]

PMID:
30526804
10.

Intensive care decision-making: Identifying the challenges and generating solutions to improve inter-specialty referrals to critical care.

Power N, Plummer NR, Baldwin J, James FR, Laha S.

J Intensive Care Soc. 2018 Nov;19(4):287-298. doi: 10.1177/1751143718758933. Epub 2018 Feb 19.

11.

Late Relapse of Ovarian Germ Cell Tumour.

Khan O, Winquist E, Ettler H, Power N.

J Obstet Gynaecol Can. 2018 Oct;40(10):1329-1332. doi: 10.1016/j.jogc.2018.02.021.

PMID:
30390946
12.

Student engagement in a Human Anatomy and Physiology course: a New Zealand perspective.

Brown SJ, Power N, Bowmar A, Foster S.

Adv Physiol Educ. 2018 Dec 1;42(4):636-643. doi: 10.1152/advan.00035.2018.

13.

Abdominal Pain Presenting as a Tight Squeeze on a Tchaikovsky Score.

Ruffle JK, Power N, Aziz Q.

Gastroenterology. 2019 Feb;156(3):e3-e5. doi: 10.1053/j.gastro.2018.09.031. Epub 2018 Sep 18. No abstract available.

PMID:
30240663
14.

Decision-making in intensive care medicine - A review.

James FR, Power N, Laha S.

J Intensive Care Soc. 2018 Aug;19(3):247-258. doi: 10.1177/1751143717746566. Epub 2017 Dec 12. Review.

15.

Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma.

Kassouf W, Monteiro LL, Drachenberg DE, Fairey AS, Finelli A, Kapoor A, Lattouf JB, Leveridge MJ, Power NE, Pouliot F, Rendon RA, Sabbagh R, So AI, Tanguay S, Breau RH.

Can Urol Assoc J. 2018 Aug;12(8):231-238. doi: 10.5489/cuaj.5462. Epub 2018 May 31. No abstract available.

16.

Drosophila melanogaster as a function-based high-throughput screening model for antinephrolithiasis agents in kidney stone patients.

Ali SN, Dayarathna TK, Ali AN, Osumah T, Ahmed M, Cooper TT, Power NE, Zhang D, Kim D, Kim R, St Amant A, Hou J, Tailly T, Yang J, Luyt L, Spagnuolo PA, Burton JP, Razvi H, Leong HS.

Dis Model Mech. 2018 Nov 16;11(11). pii: dmm035873. doi: 10.1242/dmm.035873.

17.

Case: Causation vs. correlation: Naturopathic medicine vs. natural history of a disease.

Navaratnam R, Razvi H, Power N.

Can Urol Assoc J. 2018 Nov;12(11):E484-E485. doi: 10.5489/cuaj.5058. Epub 2018 Jun 8. No abstract available.

18.

Extreme teams: Toward a greater understanding of multiagency teamwork during major emergencies and disasters.

Power N.

Am Psychol. 2018 May-Jun;73(4):478-490. doi: 10.1037/amp0000248. Review.

PMID:
29792462
19.

Images - Well-differentiated papillary mesothelioma of the tunica vaginalis.

Gan AML, Plantinga P, Punjani N, Hussey A, Power N.

Can Urol Assoc J. 2018 May 14. doi: 10.5489/cuaj.4940. [Epub ahead of print] No abstract available.

20.

A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.

Leão R, Nayan M, Punjani N, Jewett MAS, Fadaak K, Garisto J, Lewin J, Atenafu EG, Sweet J, Anson-Cartwright L, Boström P, Chung P, Warde P, Bedard PL, Bagrodia A, Freifeld Y, Power N, Winquist E, Hamilton RJ.

Eur Urol Focus. 2018 Dec;4(6):995-1001. doi: 10.1016/j.euf.2018.01.015. Epub 2018 Feb 7.

PMID:
29428550
21.

The impact of patient-, disease-, and treatment-related factors on survival in patients with adrenocortical carcinoma.

Punjani N, Clark R, Izawa J, Chin J, Pautler SE, Power N.

Can Urol Assoc J. 2018 Apr;12(4):98-103. doi: 10.5489/cuaj.4650. Epub 2017 Dec 22.

22.

The anatomy of the infrarenal lumbar splanchnic nerves in human cadavers: implications for retroperitoneal nerve-sparing surgery.

Beveridge TS, Fournier DE, Groh AMR, Johnson M, Power NE, Allman BL.

J Anat. 2018 Jan;232(1):124-133. doi: 10.1111/joa.12721. Epub 2017 Nov 21.

PMID:
29159805
23.

Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial.

Spaliviero M, Power NE, Murray KS, Sjoberg DD, Benfante NE, Bernstein ML, Wren J, Russo P, Coleman JA.

Eur Urol. 2018 Jan;73(1):53-59. doi: 10.1016/j.eururo.2017.07.038. Epub 2017 Aug 16.

24.

Management of a rare cause of significant acute upper gastrointestinal bleeding: gastric lipoma resected by hybrid endoscopic submucosal dissection.

Koukias N, Murino A, Telese A, Gaeta L, Power N, Rathbone M, Despott EJ.

Endoscopy. 2017 Oct;49(10):E246-E247. doi: 10.1055/s-0043-115002. Epub 2017 Jul 18. No abstract available.

PMID:
28719931
25.

Supplementary data: Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.

McPherson VA, Rodrigues G, Bauman G, Winquist E, Chin J, Izawa J, Potvin K, Ernst S, Venkatesan V, Sexton T, Ahmad B, Power N.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E64-E65. doi: 10.5489/cuaj.4476. Epub 2017 Feb 20. No abstract available.

26.

Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.

McPherson VA, Rodrigues G, Bauman G, Winquist E, Chin J, Izawa J, Potvin K, Ernst S, Venkatesan V, Sexton T, Ahmad B, Power N.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):24-30. doi: 10.5489/cuaj.4008.

27.

Selective Calixarene-Directed Synthesis of MXene Plates, Crumpled Sheets, Spheres, and Scrolls.

Vaughn A, Ball J, Heil T, Morgan DJ, Lampronti GI, Maršalkaitė G, Raston CL, Power NP, Kellici S.

Chemistry. 2017 Jun 16;23(34):8128-8133. doi: 10.1002/chem.201701702. Epub 2017 May 30.

PMID:
28432703
28.

Acute urinary retention secondary to urethral involvement of granulomatosis with polyangiitis.

Anderson PT, Gottheil S, Gabril M, Barra L, Power N.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E38-E40. doi: 10.5489/cuaj.3555. Epub 2017 Jan 12.

29.

Introductory anatomy and physiology in an undergraduate nursing curriculum.

Brown SJ, White S, Power N.

Adv Physiol Educ. 2017 Mar 1;41(1):56-61. doi: 10.1152/advan.00112.2016.

30.

Scrotal recurrence of germ cell tumour in a non-violated scrotum.

Li J, Power N.

Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E388-E391. doi: 10.5489/cuaj.3505. Epub 2016 Nov 10.

32.

Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guideline.

Salerno J, Finelli A, Morash C, Morgan SC, Power N, Schieda N, Haider MA.

Can Urol Assoc J. 2016 Sep-Oct;10(9-10):E332-E339. Epub 2016 Oct 13.

33.

Retroperitoneal Lymph Node Dissection: Anatomical and Technical Considerations from a Cadaveric Study.

Beveridge TS, Allman BL, Johnson M, Power A, Sheinfeld J, Power NE.

J Urol. 2016 Dec;196(6):1764-1771. doi: 10.1016/j.juro.2016.06.091. Epub 2016 Jul 5.

34.

BRCA1/2 germline testing in non-mucinous epithelial ovarian carcinoma: changing international practice and implications for service provision.

Coakley M, Cleary V, Power N, O'Reilly S.

Eur J Hum Genet. 2017 Feb;25(2):167-168. doi: 10.1038/ejhg.2016.138. Epub 2016 Oct 19. No abstract available.

35.

Calixarene Assisted Rapid Synthesis of Silver-Graphene Nanocomposites with Enhanced Antibacterial Activity.

Kellici S, Acord J, Vaughn A, Power NP, Morgan DJ, Heil T, Facq SP, Lampronti GI.

ACS Appl Mater Interfaces. 2016 Jul 27;8(29):19038-46. doi: 10.1021/acsami.6b06052. Epub 2016 Jul 14.

PMID:
27378104
36.
37.

Danger zone: Men, masculinity and occupational health and safety in high risk occupations.

Stergiou-Kita M, Mansfield E, Bezo R, Colantonio A, Garritano E, Lafrance M, Lewko J, Mantis S, Moody J, Power N, Theberge N, Westwood E, Travers K.

Saf Sci. 2015 Dec 1;80:213-220.

38.

Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma.

Tran TA, Leong HS, Pavia-Jimenez A, Fedyshyn S, Yang J, Kucejova B, Sivanand S, Spence P, Xie XJ, Peña-Llopis S, Power N, Brugarolas J.

Mol Cell Biol. 2016 Jun 15;36(13):1836-55. doi: 10.1128/MCB.00189-16. Print 2016 Jul 1.

39.

The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children.

Power RF, Linnane B, Martin R, Power N, Harnett P, Casserly B, O'Connell NH, Dunne CP.

BMC Pulm Med. 2016 Apr 22;16(1):57. doi: 10.1186/s12890-016-0219-z.

40.

National Health Models and the Adoption of E-Health and E-Prescribing in Primary Care - New Evidence from Europe.

Brennan J, McElligott A, Power N.

J Innov Health Inform. 2015 Nov 25;22(4):399-408. doi: 10.14236/jhi.v22i4.97.

41.

Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry.

Biggs CN, Siddiqui KM, Al-Zahrani AA, Pardhan S, Brett SI, Guo QQ, Yang J, Wolf P, Power NE, Durfee PN, MacMillan CD, Townson JL, Brinker JC, Fleshner NE, Izawa JI, Chambers AF, Chin JL, Leong HS.

Oncotarget. 2016 Feb 23;7(8):8839-49. doi: 10.18632/oncotarget.6983.

42.

Do retroperitoneal extragonadal germ cell tumours exist?

Punjani N, Winquist E, Power N.

Can Urol Assoc J. 2015 Nov-Dec;9(11-12):381-4. doi: 10.5489/cuaj.3024. Epub 2015 Dec 14.

43.

Novel Methods of Determining Urinary Calculi Composition: Petrographic Thin Sectioning of Calculi and Nanoscale Flow Cytometry Urinalysis.

Gavin CT, Ali SN, Tailly T, Olvera-Posada D, Alenezi H, Power NE, Hou J, St Amant AH, Luyt LG, Wood S, Wu C, Razvi H, Leong HS.

Sci Rep. 2016 Jan 14;6:19328. doi: 10.1038/srep19328.

44.
45.
46.

Penile cancer: Perspective from a Canadian tertiary care centre.

Beech B, Izawa J, Pautler S, Chin J, Power N.

Can Urol Assoc J. 2015 Sep-Oct;9(9-10):315-9. doi: 10.5489/cuaj.3230.

47.

Tracking undergraduate student achievement in a first-year physiology course using a cluster analysis approach.

Brown SJ, White S, Power N.

Adv Physiol Educ. 2015 Dec;39(4):278-82. doi: 10.1152/advan.00076.2015.

48.

Inhibition de l'extravasation des cellules de carcinomes rénaux à cellules claires par la dysregulation de la formation des invadopodes, via l'inbihition de PAK1.

Mazzola C, Williams K, Brugarolas J, Power N, Chambers A, Leong H.

Prog Urol. 2015 Nov;25(13):801-2. doi: 10.1016/j.purol.2015.08.171. French. No abstract available.

PMID:
26544365
49.

What is the effect of mandatory pasteurisation on the biogas transformation of solid slaughterhouse wastes?

Ware A, Power N.

Waste Manag. 2016 Feb;48:503-512. doi: 10.1016/j.wasman.2015.10.013. Epub 2015 Oct 20.

50.

The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.

Liu NW, Wren JD, Vertosick E, Lee JK, Power NE, Benfante NE, Kimm SY, Bains MS, Sjoberg DD, Russo P, Coleman JA.

J Urol. 2016 Feb;195(2):264-9. doi: 10.1016/j.juro.2015.08.099. Epub 2015 Sep 10.

Supplemental Content

Support Center